Login
Suchergebnis (1-20 von 34)Download
|
Symbol
|
WEVLTQ | RMASRV | XRMLTQ | AAUYSQ | RMBBNV | ABBZSQ | RMBWDV | ABJASQ | BTJBKB | ZPRLTQ | Z09D9Z | OCGRCH | RMAZBV | RMAKXV | ONHRCH | OOJRCH | AARUTQ | AAXSTQ | Z24BPZ | RMAJ2V |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Name | Multi Reverse Convertible | Multi Vonti | Worst of Reverse Convertible | Reverse Convertible | Multi Vonti | Reverse Convertible | Multi Vonti | Multi Reverse Convertible | Reverse Convertible | Worst of Callable Reverse Convertible | ZKB Reverse Convertible on worst of Last Look | Worst of Callable Reverse Convertible | Multi Vonti | Multi Vonti | Worst of Callable Reverse Convertible | Worst of Callable Reverse Convertible | Multi Reverse Convertible | Worst of Reverse Convertible | ZKB Reverse Convertible on worst of Last Look | Multi Vonti |
|
Basiswert
|
Nestlé S.A. / Novartis Sandoz Basket / Roche AG / UBS Group AG / Zurich Insurance Group AG | Nestlé S.A. / Novartis Sandoz Basket / Roche AG / Swiss RE AG / UBS Group AG | Mitsubishi UFJ Financial Group Inc. / UBS Group AG | Swiss Life Hldg. N / Swiss RE AG / UBS Group AG / Zurich Insurance Group AG | Partners Group Hldg. AG / UBS Group AG | Roche GS / Swisscom / UBS | Nestlé / Novartis / Roche GS / UBS / Zurich | Companie Financière Richemont SA / Nestlé N / Novartis N / Roche GS / UBS Group AG | Companie Financière Richemont SA / Nestlé N / Novartis N / Roche GS / UBS Group AG | Companie Financière Richemont SA / Nestlé N / Novartis N / Roche GS / UBS Group AG | BASF SE / Lonza Group N / UBS Group AG | Nestlé / Novartis / Roche GS / UBS / Zurich | Givaudan / Novartis AG / Roche AG / Sandoz Group AG / Sonova Hldg. AG / UBS Group AG | Geberit AG / Partners Group Hldg. AG / Sika AG / Sonova Hldg. AG / UBS Group AG | Lonza Group N / Nestlé S.A. / Roche AG / UBS Group AG | Barry Callebaut AG / Nestlé S.A. / Roche AG / Swiss RE AG / UBS Group AG | JPMorgan Chase & Co. / Morgan Stanley / UBS Group AG | Companie Financière Richemont SA / Nestlé N / Novartis N / Roche GS / UBS Group AG | ABB / Lonza / UBS | Nestlé / Roche GS / UBS |
|
Emittent
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fälligkeit
|
31.03.2028 | 10.02.2026 | 06.07.2026 | 18.08.2025 | 17.11.2025 | 01.12.2025 | 27.07.2026 | 08.04.2027 | 08.04.2027 | 23.04.2027 | 09.04.2025 | 26.04.2027 | 28.05.2025 | 08.06.2026 | 08.07.2026 | 15.07.2026 | 13.08.2026 | 13.09.2027 | 16.09.2025 | 17.09.2025 |
| Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Ausübungs-Preis
|
273.39 | 72.66 | 1'034.00 | 13.208 | 15.41 | 166.845 | 16.24 | 13.87 | 13.87 | 12.765 | 20.7975 | 15.8596 | 165.80 | 185.10 | 15.87 | 997.10 | 140.238 | 12.14 | 407.40 | 19.72 |
|
Maximal- rendite p.a. |
5.80% | 6.41% | - | 1.20% | 5.71% | 5.87% | 7.48% | 7.11% | 7.15% | 4.85% | -12.90% | 6.99% | 17.06% | 14.07% | 8.64% | 13.74% | 11.16% | 5.84% | 17.34% | 14.66% |
| Geld | 95.72 | - | 176.61 | 100.85 | - | 99.15 | - | 95.88 | 94.50 | 102.18 | - | 94.80 | - | - | 95.41 | 91.32 | 95.61 | 96.04 | - | - |
| Brief | 96.52 | - | 178.38 | 101.66 | - | 99.95 | - | 96.68 | 95.30 | 103.00 | - | 95.60 | - | - | 96.21 | 92.12 | 96.41 | 96.84 | - | - |
Verwendung von Cookies
Bitte warten...
Der Kursdaten-Push wurde aufgrund einer Zeitüberschreitung deaktiviert. Bitte klicken Sie auf "Seite aktualisieren", um fortzufahren.
Ihr Merkzettel (0)